Wharton's Jelly Mesenchymal Stem Cell-Derived Exosomes as an Adjunctive and Alternative Therapeutic Strategy in Spinal Disc Repair, Post-Surgical Recovery, and as a Replacement for FDA-Unindicated Epidural Corticosteroid Injections
Author: Andrew J. Hillman (ORCID 0009-0001-5396-321X)
Published: 2026-06-28, Zenodo
DOI: 10.5281/zenodo.20978822
License: CC BY 4.0
Exosome and mesenchymal stem cell-derived extracellular vesicle products are not approved by the FDA for any indication. This paper describes published scientific literature. It does not describe an available treatment.
Read the full paper at its permanent record: doi.org/10.5281/zenodo.20978822.